Meta-analysis of clinical efficacy and bleeding risk with intravenous glycoprotein IIb/IIIa antagonists for percutaneous coronary intervention

OBJECTIVE: Percutaneous coronary intervention (PCI) has become the most common mode of coronary revascularization. Inhibition of platelet aggregation via glycoprotein (GP) IIb/IIIa receptor blockade significantly reduces the acute ischemic complications associated with PCI, but the risk of bleeding...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Labinaz, Marino, Ho, Chuong, Banerjee, Srabani, Martin, Janet, Chen, Stella, Mensinkai, Shaila
Natura: Artigo
Lingua:Inglês
Pubblicazione: Pulsus Group Inc 2007
Soggetti:
Clinical Studies
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2651419/
https://ncbi.nlm.nih.gov/pubmed/17932572
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi